Showing results (2571-2580 of 31,410) with videos related to
Sort By:
Pageof 3,141
Journal of Medicinal Chemistry|July 18, 2008
Substituted 6-phenyl-2-naphthols. Potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1): design, synthesis, biological evaluation, and pharmacokineticsSandrine Marchais-Oberwinkler, Patricia Kruchten, Martin Frotscher, et al.Journal of Medicinal Chemistry|July 18, 2008
Slow self-activation enhances the potency of viridin prodrugsJoseph Blois, Hushan Yuan, Adam Smith, et al.Journal of Medicinal Chemistry|October 1, 1991
Enantioselective and diastereoselective hydroxylation of bufuralol. Absolute configuration of the 7-(1-hydroxyethyl)-2-[1-hydroxy-2-(tert-butylamino)ethyl]benzofurans, the benzylic hydroxylation metabolitesS A Weerawarna, S M Geisshüsler, S S Murthy, et al.Journal of Medicinal Chemistry|August 18, 2006
Conformation-activity relationship of designed glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosisAlfonso Carotenuto, Anna Maria D'Ursi, Barbara Mulinacci, et al.Journal of Medicinal Chemistry|August 18, 2006
1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunctionTeodozyj Kolasa, Mark A Matulenko, Ahmed A Hakeem, et al.Journal of Medicinal Chemistry|August 18, 2006
Synthesis and biological evaluation of bisindenoisoquinolines as topoisomerase I inhibitorsMuthukaman Nagarajan, Andrew Morrell, Smitha Antony, et al.Journal of Medicinal Chemistry|August 18, 2006
Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptorsDonald Sikazwe, Mikhail L Bondarev, Małgorzata Dukat, et al.Journal of Medicinal Chemistry|August 18, 2006
Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screeningIgor A Schepetkin, Andrei I Khlebnikov, Liliya N Kirpotina, et al.Journal of Medicinal Chemistry|August 1, 2009
Drug design, in vitro pharmacology, and structure-activity relationships of 3-acylamino-2-aminopropionic acid derivatives, a novel class of partial agonists at the glycine site on the N-methyl-D-aspartate (NMDA) receptor complexStephan Urwyler, Philipp Floersheim, Bernard L Roy, et al.Journal of Medicinal Chemistry|August 4, 2009
Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agentsXiaoming Yang, Qian Shi, Yi-Nan Liu, et al.Pageof 3,141